Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
about
Being right on Q: shaping eukaryotic evolutionGenipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1Mitochondrial Haplogroups and Risk of Pulmonary Arterial HypertensionEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1Silencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions.Blood Stage Plasmodium falciparum Exhibits Biological Responses to Direct Current Electric FieldsEndothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxiaInhibition of fatty acid synthase is protective in pulmonary hypertension.Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels.NADPH oxidases-do they play a role in TRPC regulation under hypoxia?Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.Techniques for Detecting Reactive Oxygen Species in Pulmonary Vasculature Redox Signaling.Lung Ischaemia-Reperfusion Injury: The Role of Reactive Oxygen Species.Electron Paramagnetic Resonance Measurements of Reactive Oxygen Species by Cyclic Hydroxylamine Spin Probes.Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountainsUncoupling Protein 2 in Cardiovascular Health and Disease
P2860
Q28077397-67625CB3-B27A-4B44-947F-089B1C367C9EQ28535681-091BEB90-4570-4B65-8E35-A654BF4EE936Q28602210-9271B60D-867E-4307-85E1-4C010ED603B2Q33608219-BFDCDD02-10FA-4129-9982-363AE009E34DQ34178976-93A28E6D-342D-4EC4-A1BC-109E823EF750Q35609951-D6D58841-87E1-4E2E-A873-02E62728C02FQ36106989-108EC54A-D274-483D-85E6-112F6018DCD9Q36490033-B0CFFD1B-0079-4F30-860E-BAEAD963C350Q36941262-F8A93E13-FA5B-42A2-93D5-328BDCA2A0DAQ38302264-10B9E279-E3D4-43A9-B6DF-C2340D693028Q38596162-B4A6CC8A-DF27-4674-AF64-8C5FCDBB5CC3Q38668387-4E108340-D494-40CC-ACCC-52D632F369F7Q39419466-0C31661D-3315-4CFE-80AA-C7DA091B441BQ46280814-97862697-6ECC-4FBC-8F26-52EA6CEC33B6Q46280862-13EE98EF-64E8-40B1-A27F-FBE74FCBCBE1Q46284086-07D719E4-8E77-44E3-BE3E-D5141FCAFC70Q47135942-EEF6C59C-2F1D-41C5-ACFA-CA3455E9C509Q47410087-CB61DC3A-50C8-43EC-9F33-EC62A836435DQ47631019-EE61C3F9-BA76-4244-A642-779E5AECEDD0Q47726007-FB49AE92-CE54-4557-9334-347E9162DFA9Q48025977-5A6919A1-625F-4D78-A544-43C068AB8144Q52312349-FF625037-184A-4AF1-ADB8-8A5DA5E3C848Q55112828-7D92A437-D692-4C0F-853E-B77C80E2EA4BQ57091761-821D5966-509C-4FAE-A60A-7E0686253786Q58335880-C85AB42B-ED3F-4F67-8E57-E16108DF9694
P2860
Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@en
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@nl
type
label
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@en
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@nl
prefLabel
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@en
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@nl
P2093
P2860
P50
P356
P1476
Mitochondrial hyperpolarizatio ...... n deficiency as disease model.
@en
P2093
Azadeh Esfandiary
Beate Fuchs
Daniela Haag
Florian Veit
Friederike Christine Weisel
Friedrich Grimminger
Matthias Hecker
Sharon Waisbrod
P2860
P304
P356
10.1165/RCMB.2012-0361OC
P50
P577
2013-09-01T00:00:00Z